Recombinant Human LTBR (C-6His)

Description

EnkiLife provides the Recombinant Human LTBR (C-6His) protein,aslo know as Tumor Necrosis Factor Receptor Superfamily Member 3,Lymphotoxin-Beta Receptor,Tumor Necrosis Factor C Receptor,Tumor Necrosis Factor Receptor 2-Related Protein,Tumor Necrosis Factor Receptor Type III,TNF-RIII,TNFR-III,LTBR,D12S370,TNFCR,TNFR3,TNFRSF3, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Lymphotoxin Beta Receptor is produced by our Mammalian expression system and the target gene encoding Gln31-Met227 is expressed with a 6His tag at the C-terminus.Accession:P36941. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:22.79 KDa. Background:Tumor necrosis factor receptor superfamily member 3, also known as Lymphotoxin-beta receptor,Tumor necrosis factor C receptor,Tumor necrosis factor receptor 2-related protein,Tumor necrosis factor receptor type III,LTBR,TNFCR, TNFR3 and TNFRSF3, is a member of the tumor necrosis factor (TNF) family of receptors. LTBR is a single-pass type I membrane protein and contains four TNFR-Cys repeats. It is expressed on the surface of most cell types, but not on T and B lymphocytes. LTBR and its ligand play a role in the development and organization of lymphoid tissue and transformed cells. Activation of LTBR can trigger apoptosis. In addition, LTBR can lead to the release of the cytokine interleukin 8.